Announcements
- EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
- EDAP to Present at the Jefferies Global Healthcare Conference
- EDAP Reports First Quarter 2024 Financial Results
- EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
- EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
- EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
- EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
- EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
- EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
More ▼
Key statistics
On Thursday, Edap Tms SA (EDA:FRA) closed at 4.60, 50.33% above the 52 week low of 3.06 set on Nov 14, 2023.
52-week range
Open | 4.64 |
---|---|
High | 4.68 |
Low | 4.60 |
Bid | -- |
Offer | -- |
Previous close | 4.62 |
Average volume | 0.00 |
---|---|
Shares outstanding | 37.10m |
Free float | 12.42m |
P/E (TTM) | -- |
Market cap | 192.95m USD |
EPS (TTM) | -0.5313 USD |
Data delayed at least 15 minutes, as of Jul 04 2024 20:55 BST.
More ▼